selegiline [Design Issues]

posted by drgunasakaran1  – 2012-09-12 16:22 (5033 d 07:43 ago) – Posting: # 9184
Views: 4,218

Dear Mr AB,
In one of our pilot study with Selegiline, we had an Intrasubject CV% of 54.3% for Cmax and 61.2% for AUC.

Dr Gunasakaran Sambandan MD
Disclaimer: The replies/posts are my personal opinions, and they do not represent my company's views on the same. LinkedIn

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
194 visitors (0 registered, 194 guests [including 88 identified bots]).
Forum time: 00:05 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5